Summary
Definition
History and exam
Key diagnostic factors
- family history of childhood seizures
- staring episode, lasting 5 to 10 seconds; several times per day with no aura/postictal state
- childhood onset
- normal physical exam
- hyperventilation-induced seizure
Other diagnostic factors
- automatisms
- recent decline in school performance
- early onset (before age 4 years)
Risk factors
- family/genetic history of absence epilepsy syndrome
- acquired brain injury: for example, hypoxia-ischemia, trauma, infection
- other congenital inborn errors of metabolism, structural defects, chromosomal abnormalities
- developmental delay or intellectual disability
Diagnostic tests
1st tests to order
- EEG
Tests to consider
- MRI brain
- testing for metabolic disorders (e.g., serum amino acids, urine organic acids, lactate pyruvate or specific enzymatic tests)
- cerebrospinal fluid glucose and serum glucose
- genetic testing
Treatment algorithm
typical absence seizures without a history of generalized tonic-clonic seizures (childhood absence epilepsy)
typical absence seizures with a history of generalized tonic-clonic seizures (CAE, JAE, JME)
atypical absence seizures
refractory to treatment
Contributors
Authors
Emily McGinnis, MD
Clinical Assistant Professor
Department of Clinical Science
Kaiser Permanente Bernard J. Tyson School of Medicine
Los Angeles
CA
Disclosures
EM states that she has no competing interests.
Dean Sarco, MD
Clinical Associate Professor
Department of Clinical Science
Kaiser Permanente Bernard J. Tyson School of Medicine
Los Angeles
CA
Disclosures
DS states that he has no competing interests.
Acknowledgements
Dr Emily McGinnis and Dr Dean Sarco would like to gratefully acknowledge Dr Michael Wong and Dr Judith L. Z. Weisenberg, previous contributors to this topic.
Disclosures
MW and JLZW declare that they have no competing interests.
Peer reviewers
Anita Devlin, MBBS, MD
Consultant Paediatric Neurologist
Royal Victoria Infirmary
NHS Foundation Trust
Newcastle-upon-Tyne
UK
Declarações
AD and two epilepsy nurses from her department have been reimbursed by UCB Pharma, the manufacturer of levetiracetam, for attending several conferences. One of the epilepsy nurses received a one-off sponsorship payment from UCB Pharma to cover the initial set-up costs of the adolescent epilepsy support group. One epilepsy nurse has been reimbursed by Cyberonics, the manufacturer of vagal nerve stimulators, for attending one or more conferences.
Cigdem Akman, MD
Division of Pediatric Neurology
Columbia University College of Physicians and Surgeons
New York
NY
Declarações
CA declares that he has no competing interests.
Angus A. Wilfong, MD
Associate Professor
Pediatrics and Neurology
Baylor College of Medicine
Medical Director
Comprehensive Epilepsy Program
Texas Children's Hospital
Houston
TX
Declarações
AAW declares that he has no competing interests.
Helen Cross, MB, ChB, PhD, FRCP, FRCPCH
Head of Neurosciences Unit
The Prince of Wales’s Chair of Childhood Epilepsy
National Centre for Young People with Epilepsy
London
UK
Declarações
HC has received research funds from HAS, Epilepsy Research UK, SHS, and the Milk Development Council. She has received funding for an epilepsy training fellowship from UCB and Eisai. She has also received travel funding from Eisai, UCB, and GlaxoSmithKline.
Créditos aos pareceristas
Os tópicos do BMJ Best Practice são constantemente atualizados, seguindo os desenvolvimentos das evidências e das diretrizes. Os pareceristas aqui listados revisaram o conteúdo pelo menos uma vez durante a história do tópico.
Declarações
As afiliações e declarações dos pareceristas referem--se ao momento da revisão.
Referências
Principais artigos
Beniczky S, Trinka E, Wirrell E, et al. Updated classification of epileptic seizures: position paper of the International League Against Epilepsy. Epilepsia. 2025 Jun;66(6):1804-23.Texto completo Resumo
Scheffer IE, Berkovic S, Capovilla G, et al. ILAE classification of the epilepsies: position paper of the ILAE commission for classification and terminology. Epilepsia. 2017 Apr;58(4):512-21.Texto completo Resumo
Hirsch E, French J, Scheffer IE, et al. ILAE definition of the idiopathic generalized epilepsy syndromes: position statement by the ILAE task force on nosology and definitions. Epilepsia. 2022 Jun;63(6):1475-99.Texto completo Resumo
Specchio N, Wirrell EC, Scheffer IE, et al. International league against epilepsy classification and definition of epilepsy syndromes with onset in childhood: position paper by the ILAE task force on nosology and definitions. Epilepsia. 2022 Jun;63(6):1398-442.Texto completo Resumo
Brigo F, Igwe SC, Lattanzi S. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents. Cochrane Database Syst Rev. 2021 Jan 21;1(1):CD003032.Texto completo Resumo
Rinaldi VE, Di Cara G, Mencaroni E, et al. Therapeutic options for childhood absence epilepsy. Pediatr Rep. 2021 Dec 16;13(4):658-67.Texto completo Resumo
Kanner AM, Ashman E, Gloss D, et al. Practice guideline update summary: efficacy and tolerability of the new antiepileptic drugs I: treatment of new-onset epilepsy: report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. 2018 Jul 10;91(2):74-81.Texto completo Resumo
Artigos de referência
Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.
Diagnósticos diferenciais
- Daydreaming
- Attention deficit hyperactivity disorder (ADHD)
- Focal impaired awareness seizures of frontal or temporal lobe origin
Mais Diagnósticos diferenciaisDiretrizes
- Epilepsies in children, young people and adults
- Teratogenesis, perinatal, and neurodevelopmental outcomes after in utero exposure to antiseizure medication
Mais DiretrizesFolhetos informativos para os pacientes
Absence seizures in children
Mais Folhetos informativos para os pacientesConectar-se ou assinar para acessar todo o BMJ Best Practice
O uso deste conteúdo está sujeito ao nosso aviso legal